Oncology and Cancer
- 11 May 2026
- 4 minutes read
- 117 Views
The 2026 Standard: Precision and Immunotherapy
In 2026, oncology has moved away from "one-size-fits-all" chemotherapy toward Precision Oncology. In Yerevan, facilities like the Yeolyan Hematology and Oncology Center and Nairi Medical Center utilize the latest molecular profiling to map a tumor's specific genetic signature.
Oncology and Cancer
- 11 May 2026
- 4 minutes read
- 68 Views
The 2026 Standard: Precision and Immunotherapy
In 2026, oncology has moved away from "one-size-fits-all" chemotherapy toward Precision Oncology. In Yerevan, facilities like the Yeolyan Hematology and Oncology Center and Nairi Medical Center utilize the latest molecular profiling to map a tumor's specific genetic signature.